Biocon Biologics
A fully integrated pure play biosimilars organization, globally engaged in developing high quality affordable biosimilars.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $800m | Debt |
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by Biocon Biologics
Edit
ACQUISITION by Biocon Biologics Jun 2022